Finally, and very strikingly, we show that the MYC/TERT/NFκB molecular axis, described as mediating miR196a oncogenic activity in EAC cells, is also operating in BE patients and, most importantly, is hyperactive by the time of biopsy extraction for the diagnosis of BE. This evidence concerns the gene NFKB1 and Barrett esophagus.